Management of National and Regional Immunization Programmes: Current Challenges and Future Strategies
Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 20465
Interests: vaccination services; vaccine safety; vaccine hesitancy; antimicrobial stewardship; rational medicines use
Interests: clinical pharmacy; pharmacoepidemiology and pharmacovigilance; infectious diseases including vaccines; non- communicable disease; implementation science in global health (dissemination research); evidence based research and policy
2. Department of Public Health Pharmacy and Management, School of Pharmacy, SMU, Pretoria, South Africa
3. Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates
Interests: immunization programmes; vaccine management; vaccine hesitancy; pricing of vaccines; evidence based health policy; medicines utilisation; antimicrobial resistance
In these challenging times of rising infection and cancer rates, particularly in low- and middle-income countries, it is essential that countries learn from each other in order to improve future access to vaccines and vaccination coverage where there are concerns across all target groups. As a result reduce future morbidity and mortality, including mortality due to antimicrobial resistance from inappropriate prescribing of antimicrobials. We welcome original research papers and reviews on these key topics, with insights and suggested ways forward for immunization programmes to enhance public health, including those for COVID-19. Topics of interest include, but are not limited to, issues and challenges surrounding vaccines, including vaccine hesitancy and vaccine uptake, strategies to address misinformation and build vaccine confidence, and key economic considerations, including affordability. Waivers and reduced publication fees will be available on request for a limited number of papers that will enhance this Special Issue, especially those from low- and low-middle income countries.
Prof. Dr. Johanna C Meyer
Dr. Sylvia Opanga
Prof. Dr. Brian Godman
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- public health